Merit Medical Systems, Inc.

NASDAQ:MMSI

Medical - Instruments & Supplies

Healthcare
$85.93 +1.77%

+$1.16 today

Market cap
$5.15B
Beta
0.53
P/E (TTM)
28.4
EPS (TTM)
$2.34
52W Low $59.74High $96.74

Volume 0.46M

Average 0.79M

MMSI Operating Cash Flow

Cash generated by the company's core business operations during the period.

Merit Medical Systems, Inc.NASDAQ: MMSI

Operating Cash Flow · Q3 FY2026 · quarter ended Sep 2026

Operating cash flow dips below year-ago levels

Q3 FY2026 operating cash flow of $65.27M fell 12.9% year over year, behind the +2.3% change in trailing-twelve-month operating cash flow. Sequentially, it fell 5.8% from the prior quarter. Over 3 fiscal years it compounded at +37.5% a year.

Context

  • Operating cash flow amounted to 19.6% of revenue in FY2025, up 3.4 pp from a year earlier.
  • Operating cash flow increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -12.9% toward the trailing-twelve-month pace of +2.3%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
$65.27M-5.8% QoQ
Last fiscal yearDec 2025
$297.37M+34.7% YoY
LTMSep 2026
$273.74M+2.3% YoY
Operating Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-12.9%——
1 year+34.7%——
3-year CAGR+37.5%——
5-year CAGR——
10-year CAGR——

Operating Cash Flow history

USD · from the cash flow

Latest · FY2025
297.37M USD
Year-over-year change
+34.7%
4-year CAGR
+19.2%

Operating Cash Flow vs competitors

How MMSI compares with its peers on the latest reported figures

  • MMSI's LTM Sep 2026 operating cash flow of $273.74M is the 4th largest of the 10 companies compared; the peer median is $209M.
  • Its year-over-year change of +2.3% is the 6th highest of 10, against a peer median of +5.7%.
  • Operating cash flow amounts to 17.0% of revenue for MMSI, versus a peer median of 11.4%.
MMSI Competitors Peer median
Operating Cash Flow for MMSI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BSXBoston Scientific CorporationLTM Jun 2026$4.53B +5.7%+43.8%21.6%
BDXBecton, Dickinson and CompanyLTM Sep 2026$3.48B +1.5%+6.4%17.2%
TFXTeleflex IncorporatedLTM Jun 2026$402.44M -21.7%-0.1%15.5%
MMSIMerit Medical Systems, Inc.LTM Sep 2026$273.74M +2.3%+37.5%17.0%
ICUIICU Medical, Inc.LTM Jun 2026$236.37M +70.3%—10.9%
SOLVSolventum CorporationLTM Jun 2026$209M -64.3%-39.7%2.5%
CNMDCONMED CorporationLTM Mar 2026$142.63M -20.5%+72.3%10.4%
LMATLeMaitre Vascular, Inc.LTM Mar 2026$87.31M +81.5%+47.4%34.1%
ATRCAtriCure, Inc.LTM Jun 2026$64.94M +78.3%—11.4%
ANGOAngioDynamics, Inc.LTM Feb 2026$4.45M +118.6%+12.1%1.4%
Peer median (excluding MMSI) $209M+5.7%+12.1%11.4%

Competitors are the stored peer set for MMSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income48.45M74.52M94.41M120.36M128.49M
Depreciation & Amortization95.78M92.2M101.29M114.73M134.65M
Deferred Income Tax(4.63M)(14.92M)(12.64M)(14.87M)5.21M
Stock-Based Compensation16.09M18.04M21.33M28.47M43.46M
Change in Working Capital(17.84M)(71.4M)(70.02M)(36.95M)(23.34M)
Accounts Receivables(8.62M)(15.12M)(9.55M)(21.7M)(2.73M)
Inventory(25.18M)(47.93M)(32.11M)(2.29M)(21.6M)
Accounts Payables6.05M12.66M(7.3M)(2.31M)1.01M
Other Working Capital9.91M(21.01M)(21.08M)(10.64M)(26K)
Other Non-Cash Items9.37M15.86M10.78M9.06M8.9M
Operating Cash Flow147.23M114.29M145.15M220.8M297.37M
Capital Expenditures(27.94M)(45.03M)(36.7M)(38.04M)(84.84M)
Acquisitions (Net)(7.17M)(8.29M)(137.85M)(320.18M)(144.77M)
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(2.05M)(4.08M)(799K)(10.43M)(17.78M)
Investing Cash Flow(37.16M)(57.4M)(175.35M)(368.65M)(247.39M)
Debt Repayment(108.5M)(44.94M)619.58M(99.06M)0
Common Stock Issued21.31M20.07M15.58M40.91M28.21M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(11.24M)(35.39M)(75.9M)(1.85M)(12.21M)
Financing Cash Flow(98.44M)(60.26M)559.27M(60.01M)16M
Effect of Forex Changes(801K)(3.83M)(484K)(2.52M)3.8M
Net Change in Cash10.83M(7.19M)528.59M(210.38M)69.78M
Free Cash Flow119.29M69.26M108.45M182.76M212.54M

Merit Medical Systems, Inc.

NASDAQ:MMSI

Intrinsic Alpha fair value

Locked

Current Price

$85.93

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.